Apoptosis and necroptosis are complementary pathways controlled by common signalling adaptors, kinases and proteases; among these, caspase-8 (Casp8) is critical for death receptor-induced apoptosis. This caspase has also been implicated in non-apoptotic pathways that regulate Fas-associated via death domain (FADD)dependent signalling and other less defined biological processes as diverse as innate immune signalling and myeloid or lymphoid differentiation patterns 1 . Casp8 suppresses RIP3-RIP1 (also known as RIPK3-RIPK1) kinase complex-dependent 2-4 necroptosis 5 that follows death receptor activation as well as a RIP3-dependent, RIP1independent necrotic pathway that has emerged as a host defence mechanism against murine cytomegalovirus 6 . Disruption of Casp8 expression leads to embryonic lethality in mice between embryonic days 10.5 and 11.5 (ref. 7) . Thus, Casp8 may naturally hold alternative RIP3-dependent death pathways in check in addition to promoting apoptosis. We find that RIP3 is responsible for the mid-gestational death of Casp8-deficient embryos. Remarkably, Casp8 2/2 Rip3 2/2 double mutant mice are viable and mature into fertile adults with a full immune complement of myeloid and lymphoid cell types. These mice seem immunocompetent but develop lymphadenopathy by four months of age marked by accumulation of abnormal T cells in the periphery, a phenotype reminiscent of mice with Fas-deficiency (lpr/lpr; also known as Fas). Thus, Casp8 contributes to homeostatic control in the adult immune system; however, RIP3 and Casp8 are together completely dispensable for mammalian development.
To determine whether Casp8 can hold RIP3 kinase-dependent death [2] [3] [4] [5] 8 in check, we used murine L929 cells, a system that requires continued Casp8 expression for cell survival 9 . Inhibition of Casp8 with either small interfering RNA (siRNA; Supplementary Fig. 1a ) or zVAD-fmk ( Supplementary Fig. 1c ) induced death, as expected from previous studies 9 . When treated with RIP3-specific short hairpin RNA (shRNA), however, L929 cells were protected from death (Supplementary Fig. 1a ), consistent with this being a RIP3-dependent necrotic death pathway. The murine cytomegalovirus (MCMV) M45 geneencoded viral inhibitor of RIP activation (vIRA) blocks RIP3-dependent necrotic death 6 . In keeping with the importance of a RIP3-RIP1 complex in necroptosis [2] [3] [4] , vIRA blocked death, whereas a tetra-alanine RIP homotypic interaction motif (RHIM) substitution mutant, M45mutRHIM 6 failed to suppress death induced by either Casp8 siRNA or zVAD ( Supplementary Figs 1b, d ). Necrostatin-1 was used to demonstrate that RIP1 kinase activity was necessary for necroptosis ( Supplementary Fig. 1c ). The specific viral inhibitor of Casp8 activation (vICA) encoded by the MCMV M36 gene 10 also induced this death pathway ( Supplementary Fig. 1e , f). These data demonstrate that L929 cells succumb to RIP3-dependent necrotic death when Casp8 is inactive or eliminated.
Disruption of Casp8 expression leads to embryonic lethality in mice between embryonic day 10.5 (E10.5) and E11.5, coincident with embryonic vascular, cardiac and haematopoietic defects 7, [11] [12] [13] ; however, the molecular mechanisms behind these defects remain poorly defined 7, [11] [12] [13] . To evaluate the potential contribution of RIP3 to embryonic lethality, we examined wild-type and Casp8 2/2 embryos as well as extra-embryonic tissues for Rip3 expression. On the basis of in situ hybridization, Rip3 transcript levels increased and tissue distribution broadened as embryonic development proceeded from E9.5 to E12.5 in both genotypes, indicating that Rip3 transcript is not regulated by Casp8 ( Fig. 1a and data not shown). At E9.5, Rip3 was prominent in the apical ectodermal ridge (AER) of the hind-limb bud and the tail bud, and expanded to include the fore-limb bud AER, midline of the spinal cord, branchial arches and intersomitic regions by E10.5 through E12.5 ( Fig. 1a and data not shown), a signal that was absent from RIP3deficient E10.5 embryos ( Fig. 1b ). Additionally, RIP3 was readily detected by immunoblot in E10.5 embryo and yolk sac cell lysates (data not shown). Mice homozygous for disruption of exons 3 and 4 in Casp8 (ref. 14) died by E11.5 and presented with heart defects, hyperaemia in the abdominal region, and undulation of the neural tube ( Fig. 1c and Supplementary Fig. 2a ), consistent with earlier studies that used alternative targeting strategies to disrupt Casp8 (refs 7, 11, 13) .
The yolk sac is the initial site of haematopoiesis before the transfer of function to intra-embryonic sites. The most pronounced impact of Casp8 disruption, either in embryonic tissues or in the yolk sac, is the disruption of endothelial cell organization leading to circulatory failure in the yolk sac, the probable culprit behind embryonic lethality 11, 13 . When we used PECAM-specific antibody to localize endothelial cells in Casp8-deficient embryos (E10.5), we observed the expected contrast between an organized yolk sac vascular pattern in control mice and a disrupted pattern in Casp8-deficient mice (Fig. 1d ). These observations affirmed the disruption of vascular development in Casp8 null embryos. RIP3 was also detected in the yolk sac endothelium of both Casp8 1/2 Rip3 1/2 and Casp8 2/2 Rip3 1/2 embryos at this time (Supplementary Fig. 2b) ; thus, RIP3 was present in the cell populations most widely implicated in embryonic death of Casp8-deficient mice independently of Casp8 expression. Casp8 deficiency is also known to compromise primitive haematopoietic progenitor cell (HPC) development 7 , a process dependent on CD41 1 cells populating yolk sac blood islands and fetal sites 15 . RIP3 was detected in CD41 1 cells in the yolk sac blood islands of embryos ( Fig. 1e and Supplementary Fig. 2c ). The striking CD41 1 cell fragmentation in the yolk sac blood islands of Casp8 2/2 Rip3 1/2 embryos at E10.5 further implicates this kinase in processes leading to embryonic death.
To establish the role of the RIP3 kinase in embryonic lethality of Casp8-deficient mice, we generated double knock out (DKO) Casp8 2/2 Rip3 2/2 embryos by a Casp8 1/2 Rip3 1/2 intercross. In contrast to Casp8 2/2 Rip3 1/2 embryos, which were developmentally arrested at ,E11.0, DKO embryos were indistinguishable from Casp8 1/2 Rip3 2/2 or Casp8 1/2 Rip3 1/2 embryos at E12.5 and later times, had a functioning heart and organized yolk sac endothelial architecture and, remarkably, exhibited HPC colony formation at levels comparable to wild-type mice (Fig. 1f, g and Supplementary  Fig. 2d and data not shown). The apparent normalization of the Casp8deficient phenotype by removal of RIP3 indicated that this kinase was responsible for the ,E11.0 embryonic block, so we permitted the intercross pregnancies to complete gestation. PCR analysis performed on tissues from weanling mice confirmed deletion of Casp8 exons 3-4 as well as deletion of Rip3 in both alleles (Supplemental Fig. 3a ). We detected RIP1, Casp8 and RIP3 in spleen and thymus from wild-type mice examined by immunoblot ( Fig. 2a ). Casp8 1/1 Rip3 2/2 , Casp8 1/2 Rip3 2/2 and DKO mice all lacked RIP3 but retained unaltered RIP1 levels in tissues. Casp8 was absent from DKO mice but present in other intercross progeny with predicted Mendelian frequencies ( Fig. 2b ). As expected, Casp8-deficient, RIP3-expressing progeny were not seen. Furthermore, when bred, adult DKO mice gave birth to viable mice that survived through adulthood and appeared similar to Casp8 1/2 Rip3 2/2 mice bred in parallel ( Supplementary Fig. 3b ). Earlier studies showed that conditional deletion of Casp8 in epidermis promoted perinatal lethality characterized by chronic inflammation 16, 17 . DKO mice did not exhibit any evidence of skin inflammation when followed for more than 6 months, indicating that RIP3 must have had a proinflammatory role in the absence of epithelial Casp8 in prior studies. These results further indicate that embryonic lethality as well as a range of vascular degeneration and neural tube defects, together with haematopoietic abnormalities and chronic inflammation seen in mice lacking Casp8 are all RIP3-dependent.
To verify the functional elimination of Casp8 in cells derived from DKO animals, we evaluated susceptibility to inducers of death receptor (DR)-mediated apoptosis. Although Casp8 has an essential role in macrophage differentiation 11 , DKO mice produced CD11b 1 F4/80 1 bone marrow-derived mononuclear (BMDM) cells just as readily as controls, and these cells lacked detectable RIP3 or Casp8 ( Fig. 3a and  b) . Thus, the requirement for Casp8 during macrophage differentiation is suppressed by RIP3-deficiency. Macrophages prepared from wild-type, Casp8 1/1 Rip3 2/2 and Casp8 1/2 Rip3 2/2 mice died when exposed to reagents promoting Fas activation, whereas DKO cells were completely resistant, consistent with the established role of this caspase in DR-induced apoptosis. In the presence of the caspase inhibitor zVAD-fmk, Fas activation promoted RIP3-dependent necroptosis in RIP3-containing BMDM cells ( Fig. 3c ). Furthermore, cells expressing RIP3 were susceptible to necroptosis, whereas Rip3 knockout and DKO mice remained resistant to this death pathway. Thus, DKO cells were insensitive to either extrinsic DR-induced apoptosis or RIP3dependent necroptosis, consistent with their genotype. Previously, conditional knockout of Casp8 in the liver revealed its essential role in TNF or Fas-induced fatal hepatitis 11, 18 . DKO mice were resistant to anti-Fas-antibody treatment, survived for over 48 h ( Fig. 3d ) and showed normal liver architecture ( Fig. 3e ), although they exhibited slightly elevated levels of the liver-associated transaminases ALT (alanine aminotransferase) and AST (aspartate aminotransferase) (data not shown). In contrast, Casp8 1/2 Rip3 2/2 littermate control mice developed hepatitis ( Fig. 3d and 3e ). DKO mice were also resistant to administration of LPS in combination with the liver-specific transcriptional inhibitor D-(1) galactosamine (GalN), which induces a TNF-dependent fatal liver hepatitis in both wild-type 18 and Casp8 1/1 RIP3 2/2 mice ( Supplementary Fig. 4 ). This resistance was comparable to the negative control TRIF-deficient mice 19 (also known as TICAM1; Supplementary  Fig. 4 ).
Although RIP3 is dispensable for myeloid and lymphoid development 20 , Casp8 is essential for generation of both myeloid and lymphoid lineages 11, 14, 21, 22 . To determine whether this essential role of Casp8 was due to dysregulation of RIP3, we evaluated the characteristics of leukocytes from the thymus, bone marrow, spleen and lymph node LETTER RESEARCH (LN) of DKO mice, littermate Casp8 1/2 Rip3 2/2 and wild-type mice (Fig. 4a ) by fluorescence-activated cell sorting (FACS) analysis, detecting the presence of myeloid and lymphoid populations in all three genotypes based on forward (size) and side (granularity) light scatter properties (data not shown) in combination with surface markers. We observed inflammatory monocytes (CD11b 1 Ly6C hi ) and polymorphonuclear leukocytes (CD11b 1 Ly6C int ) in the bone marrow and spleen (Fig. 4a ) of wild-type and DKO mice. On the basis of CD11c and F4/80 expression, dendritic cells and macrophages, respectively, populated the same tissues of DKO and Casp8 1/2 Rip3 2/2 littermate controls (data not shown). Thus, myeloid cell populations continued to be generated in the absence of RIP3 and Casp8, consistent with the successful derivation of BMDM cells from DKO mice (see Fig. 3 ). NK (CD49b 1 CD3 -), NKT (CD49b 1 CD3 1 ) and B (CD19 1 ) lymphocytes, including predominant IgD 1 as well as less prevalent IgD -B cells (data not shown) were present in all tissues examined (Fig. 4a) . Defects in the Fas (CD95)-death receptor pathway promote the accumulation and expansion of lymphocytes and the development of autoimmune lymphoproliferative syndromes (ALPS) 23 . Caspase-8 is downstream of Fas, and similarly DKO mice showed pronounced splenomegaly and lymphadenopathy over the first few months of age ( Supplementary Fig. 5a-c) . Adult DKO mouse spleens ranged from three to seven times the size of Casp8 1/2 Rip3 2/2 littermate controls ( Fig. 4b and Supplementary Fig. 5b, c) and contained more lymphoid cells in splenic white pulp (data not shown). Histological examination revealed lymphocytic infiltrates in the salivary glands, pancreas and lamina propria of both stomach and small intestine (data not shown). Consistent with size, DKO mice had significantly greater numbers of leukocytes in secondary lymphoid tissues such as spleen (Supplementary Fig. 5d ) that seemed to result from abnormally high levels of CD3 1 T cells and to a lesser degree CD19 1 B cells ( Supplementary  Fig. 5e ). Whereas these characteristics are consistent with the known role of Casp8 in DR-associated haematopoietic homeostasis 23 , they contrast with the characteristics of mice with Casp8-deficient T cells, where there are fewer T cells than B cells in secondary lymphoid tissues 14, 22 . Thus, there was a marked accumulation of T cells that contributed to lymphadenopathy and splenomegaly as DKO mice aged.
Casp8-deficient T cells show defects in the response to antigens and mitogens 14, 24 . To compare T-cell activation in DKO and Casp8 1/2 Rip3 2/2 littermate controls, we evaluated the sensitivity of bulk splenocytes from mock and MCMV-infected mice, to anti-CD3 and anti-CD28 treatment. In contrast to earlier observations on Casp8-deficient T cells 14, 24 , this treatment induced a response in mock-infected DKO cells and this response was enhanced at 7 days post MCMV infection. In fact, the CD8 T cells from DKO mice responded with an increased frequency in bifunctional INFc 1 TNF 1 cells (Fig. 4c ). Furthermore, DKO mice survived a dose of virus that is lethal to immunocompromised scid/scid (also known as Prkdc) mice and maintained control over viral replication levels for 30 days, similar to Casp8 1/2 Rip3 2/2 littermate controls (data not shown). Although more characterization is required to understand fully the quality of the immune response in DKO mice, T cell receptor-dependent activation of naive and enhanced activation of antigen-exposed T cells is clearly retained despite the combined disruption of Casp8 and Rip3.
Fas-deficient (lpr/lpr) mice are marked by the accumulation in the periphery of the CD3 1 T cells that are B220 1 but lack CD4 and CD8; these cells have been ascribed to a failure of apoptosis 25 . DKO mice had normal CD4 and CD8 T-cell populations in the thymus (Supplementary Fig. 5f ), but contained this signature B220 1 T cell population in secondary lymphoid organs ( Fig. 4d and Supplementary Fig. 5g ). Interestingly, conditional deletion of Casp8 in T cells, although resulting in lymphadenopathy, did not result in the emergence of this signature phenotype 22 , indicating that RIP3-dependent necroptosis eliminates T cells where Casp8 is absent or non-functional. Thus, Fas DR-induced death pathways are essential for immune homeostasis and in the absence of both Casp8 and RIP3, excess unusual T cells probably accumulate owing to a failure of both apoptosis and necroptosis.
The data presented here point to RIP3 as the vital target of Casp8 during mammalian development, with Casp8 functioning during embryogenesis to restrict RIP3 rather than to mediate apoptosis. We speculate that the RIP3-dependent pathway controlled by Casp8 in the vasculature and haematopoietic cells during embryogenesis, as well as in other tissues where Casp8 deficiency leads to cell death, is related to known necrotic pathways controlled by this kinase. Eliminating this RIP3-dependent embryonic death in combination with Casp8-deficiency results in the accumulation of abnormal T cells as adult animals age, but does not lead to defects at other developmental stages. Although Casp8 may have other non-apoptotic roles such as influencing cell motility and proliferation, one of its key roles is its essential non-apoptotic function to control RIP3. FADD promotes Casp8 activation within the death-inducing signalling complex (DISC), a process subject to regulation by cFLIP. Deletion of FADD, cFLIP or Casp8 in all tissues causes a common pattern of vascular and haematopoietic defects associated with embryonic lethality in mice around E10.5 (ref. 1), suggesting the coordinated control of RIP3 by these three players during development. The signals controlling activation of Casp8 and/or RIP3 during embryogenesis remain to be identified. Nevertheless, therapeutic strategies targeting DISC components aimed at apoptosis will need to take into account the likely triggering of RIP3dependent pathways. Upon combined elimination of Casp8 and RIP3, Animal Care and Use Committee. Immunoblotting, preparation of protein extracts, and immunoprecipitations were as described previously 27 . Whole-mount in situ hybridization was performed as described 28 , with digoxigenin-labelled antisense RNA probes transcribed from linearized RIP3-encoding plasmid (accession number BC029210, ATCC) according to the manufacturer's directions (Roche). Yolk sacs were fixed and stained for immunofluorescence microscopy by standard methods, and images were acquired on a Carl Zeiss LSM 510 META confocal fluorescence microscope. Bone-marrow-derived macrophages were generated and viability determined as described previously 6 . Cells for flow cytometry were harvested, processed and stained with indicated antibodies by standard methods. Data were acquired using an LSRII flow cytometer (BD Biosciences) and analysed with FlowJo software. LETTER RESEARCH
